The purpose of the present invention is to provide novel complexes that improve the effect of nucleic acid medicines.Provided is a complex in which a multibranched lipid(s) binds through a linker to a strand of an oligonucleotide comprising a nucleic acid medicine having suppressing activity of the target gene expression.